Balancing risk-benefit ratio in donors of gut biopsy samples for HIV persistence research
Saved in:
Main Authors: | J.-P. Routy (Author), R. Ramendra (Author), P. Ghali (Author), C. Costiniuk (Author), B. Lebouché (Author), R. Ponte (Author), R. Reinhard (Author), J. Sousa (Author), N. Chomont (Author), E. Cohen (Author), P. Ancuta (Author), V. Mehraj (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
by: Vikram Mehraj, et al.
Published: (2017) -
Marker of gut damage REG3α and microbial translocation are associated with integrated HIV DNA in CD4 T cells during early HIV infection
by: S. Isnard, et al.
Published: (2019) -
Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV
by: S. Isnard, et al.
Published: (2019) -
Soluble ST2 rings the alarm for gut damage and immune activation in primary HIV infection
by: Vikram Mehraj, et al.
Published: (2016) -
OA4-2 HIV persists in colon and blood CCR6+CD4+ T cells during ART
by: A. Gosselin, et al.
Published: (2016)